Washington state has passed a bill that prohibits the use of elephants, bears, wild cats, and nonhuman primates in circuses ...

Bio (IBIO) announced data from a non-GLP non-human primate pharmacokinetics study suggesting IBIO-600, the company’s novel lead asset and a ...

Animal research remains critically important in the work of preventing, treating and eradicating debilitating diseases, write ...

The tactic is the latest—and perhaps boldest—among many undertaken by the Physicians Committee for Responsible Medicine to ...

Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as 130 days Additional interim in ...

Continues to Strengthen Its Pandemic Preparedness and Biodefense Vaccine Portfolio ATLANTA, GA - April 9, 2025 (NEWMEDIAWIRE) ...

(RTTNews) - iBio, Inc. (IBIO) Monday reported encouraging data from a non-GLP non-human primate (NHP) pharmacokinetics study of the company's lead drug candidate IBIO-600 for the treatment of obesity.

Sangamo Therapeutics Inc., a genomic medicine company, has entered into a license agreement with Eli Lilly and Company.

The study titled ‘Genomic Basis of Non-Human Primate Diversity and Adaptation' in Nature Reviews Biodiversity combines decades of data and uses high-resolution genome sequencing to explore how ...

Sacramento, CA– A California bill to prohibit public interactions with captive wild animals will have its first hearing ...

A team of researchers traced the wild animal source of monkeypox virus to the fire-footed rope squirrel Funisciurus pyrropus ...